Protagonist Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Protagonist Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Protagonist Therapeutics Inc Strategy Report
- Understand Protagonist Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Protagonist Therapeutics Inc (Protagonist) is a clinical-stage biopharmaceutical company that discovers and develops orally stable peptides as targeted therapies. The company through its proprietary technology platform develops structurally novel oral or injectable peptides for protein-protein interaction targets. Its peptides specifically target biological pathways that are also targeted by currently marketed injectable antibody drugs. Protagonist’ product candidates are intended for the treatment of inflammatory bowel disease and other gastrointestinal diseases and hematological disorders. The company has its operations in the US and Australia. Protagonist is headquartered in Milpitas, California, the US.
Protagonist Therapeutics Inc premium industry data and analytics
Products and Services
Products |
---|
Pipeline |
PTG-300: |
Beta- Thalassemia |
XYZ |
XYZ |
XYZ |
Competitor Comparison
Key Parameters | Protagonist Therapeutics Inc | UCB SA | Rigel Pharmaceuticals Inc | Arena Pharmaceuticals Inc | Janssen Pharmaceuticals Inc |
---|---|---|---|---|---|
Headquarters | United States of America | Belgium | United States of America | United States of America | United States of America |
City | Newark | Anderlecht | South San Francisco | San Diego | Titusville |
State/Province | California | - | California | California | New Jersey |
No. of Employees | 112 | 9,083 | 147 | 448 | 10,400 |
Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Harold E. Selick | Chairman | Executive Board | 2017 | 68 |
Dinesh V. Patel | Chief Executive Officer; Director; President | Executive Board | 2008 | 66 |
Asif Ali | Chief Financial Officer; Executive Vice President | Senior Management | 2022 | 49 |
Mohammad Masjedizadeh | Chief Technology Officer; Executive Vice President | Senior Management | 2021 | - |
Arturo Molina | Chief Medical Officer | Senior Management | 2022 | 64 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer